Effects of the Partial M1 Muscarinic Cholinergic Receptor Agonist CDD-0102A on Stereotyped Motor Behaviors and Reversal Learning in the BTBR Mouse Model of Autism.

MLA

Athnaiel, Onella, et al. “Effects of the Partial M1 Muscarinic Cholinergic Receptor Agonist CDD-0102A on Stereotyped Motor Behaviors and Reversal Learning in the BTBR Mouse Model of Autism.” The International Journal of Neuropsychopharmacology, vol. 25, no. 1, Jan. 2022, pp. 64–74. EBSCOhost, https://doi.org/10.1093/ijnp/pyab079.

APA

Athnaiel, O., Job, G. A., Ocampo, R., Teneqexhi, P., Messer, W. S., & Ragozzino, M. E. (2022). Effects of the Partial M1 Muscarinic Cholinergic Receptor Agonist CDD-0102A on Stereotyped Motor Behaviors and Reversal Learning in the BTBR Mouse Model of Autism. The International Journal of Neuropsychopharmacology, 25(1), 64–74. https://doi.org/10.1093/ijnp/pyab079

Chicago

Athnaiel, Onella, Greeshma A Job, Roberto Ocampo, Pamela Teneqexhi, William S Messer, and Michael E Ragozzino. 2022. “Effects of the Partial M1 Muscarinic Cholinergic Receptor Agonist CDD-0102A on Stereotyped Motor Behaviors and Reversal Learning in the BTBR Mouse Model of Autism.” The International Journal of Neuropsychopharmacology 25 (1): 64–74. doi:10.1093/ijnp/pyab079.